Skip to main content

and
  1. Article

    Open Access

    Vosoritide Therapy in Children with Achondroplasia: Early Experience and Practical Considerations for Clinical Practice

    Vosoritide is the first precision medical therapy approved to increase growth velocity in children with achondroplasia. Sharing early prescribing experiences across different regions could provide a framework ...

    Oliver Semler, Valérie Cormier-Daire, Ekkehart Lausch in Advances in Therapy (2024)

  2. Article

    Open Access

    Multiple endocrine neoplasia type 1 presenting with concurrent insulinoma and prolactinoma in early-adolescence

    Multiple Endocrine Neoplasia Type 1 (MEN1) is a rare autosomal dominant disease that generally presents with primary hyperparathyroidism. However, initial presentation may vary and continued reevaluation of et...

    Yasmin Akhtar, Angela Verardo in International Journal of Pediatric Endocri… (2018)